Please provide your email address to receive an email when new articles are posted on . Ocular conditions in women depend on several factors, including genes, hormones, comorbidities, physiological ...

Many women ignore early eye symptoms while prioritising family and work responsibilities. Experts say recognising warning ...

A special issue (http://online.liebertpub.com/toc/jop/31/7) of Journal of Ocular Pharmacology and Therapeutics highlights the latest research on matricellular ...

Please provide your email address to receive an email when new articles are posted on . Ocular manifestations appeared common among patients with primary immunodeficiency diseases, suggesting a need ...

Common eye diseases include age-related macular degeneration, amblyopia, cataracts, diabetic retinopathy, dry eye, and glaucoma. Over time, tissue damage in different parts of the eye can lead to ...

The system, aptly named iTEARS, uses "cellular messengers" in tears to determine whether a certain disease is present in the human body. Share on Facebook (opens in a new window) Share on X (opens in ...

Share on Pinterest An experimental CRISPR-based gene editing treatment significantly improved vision outcomes in subjects with a rare eye disorder. Robert Nickelsberg/Getty Images Researchers from ...

Cataracts, pinkeye and other ocular disorders are linked to heat, air pollution and higher UV exposure Sanket Jain, Knowable Magazine For five months in 2017, farmworker Alka Kamble experienced ...

University of Pittsburgh School of Medicine researchers have developed an early-stage, experimental "living eye drop" that uses naturally occurring eye bacteria to support corneal wound healing. The ...

Ocular Therapeutix (OCUL) has been making extensive progress in being able to advance the use of its Elutyx technology to advance several drug candidates to treat patients with eye disorders. The ...

Ocular Therapeutix Inc. (NASDAQ: OCUL) shares are down during Tuesday's premarket session following a significant announcement regarding their Axpaxli treatment for wet age-related macular ...